CME

CME


Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy - Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

July 09, 2021

Guest: Kevan C. Herold, MD

Guest: Andrea Steck, MD

Guest: Anette Gabriele Ziegler, MD

Experts in the immunopathology of type 1 diabetes review data showing that clinical presentation is preceded by an asymptomatic phase, characterized by the pres